NCT06652633 - Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies | Biotech Hunter

Enrollment

546

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

July 31, 2039

Study Completion Date

July 31, 2039

Conditions

Hematological Malignancies

Interventions

GENETIC

GLPG CAR T-cell therapy

No investigational products will be administered to participants in this study.

Trial Locations (6)

RECRUITING

Antwerp University Hospital, Edegem

RECRUITING

Centre Hospitalier Universitaire (CHU) De Liège, Liège

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

Academisch Medisch Centrum, Amsterdam

RECRUITING

Leids University Medical Center (LUMC), Leiden

RECRUITING

Hospital Clinic De Barcelona, Barcelona